Skip to content

Clinical trials

Completed Phase 1/2 Pseudomonas Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pseudomonas Infections Phase: Phase 1/2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20083
20201
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Humanigen, Inc.2
Armata Pharmaceuticals, Inc.1
Immunsystem AB1
Kenta Biotech Ltd1
National Institute of Allergy and Infectious Diseases (NIAID)1
Respirion Pharmaceuticals Pty Ltd1
Technophage, SA1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pseudomonas Infections9
Cystic Fibrosis6
Pneumonia, Ventilator-Associated2
Acinetobacter Infections1
Bronchiolitis Obliterans Syndrome1
Diabetic Foot1
Healthcare-Associated Pneumonia1
Infections1
Pneumonia1
Recurrence1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.